Get started
Author

Aram Vosoughi

Patient derived organoids to model rare prostate cancer phenotypes
2018 · Loredana Puca, Rohan Bareja, et al. · Nature Communications · 361
PDF
ONECUT2 is a driver of neuroendocrine prostate cancer
2019 · Haiyang Guo, Xinpei Ci, et al. · Nature Communications · 243
PDF
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
2019 · Loredana Puca, Katie Gavyert, et al. · Science Translational Medicine · 212
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
2020 · Deli Liu, Jonathan E. Shoag, et al. · Nature Communications · 74
Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease
2023 · Kyle M. Rose, Heather L. Huelster, et al. · Nature Reviews Urology · 65
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
2018 · Habiba Elfandy, Joshua Armenia, et al. · Molecular Cancer Research · 59
A Targeted and Adjuvanted Nanocarrier Lowers the Effective Dose of Liposomal Amphotericin B and Enhances Adaptive Immunity in Murine Cutaneous Leishmaniasis
2013 · Pirouz M. Daftarian, Geoffrey W. Stone, et al. · The Journal of Infectious Diseases · 56
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non–organ-confined Upper Tract Urothelial Carcinoma
2023 · Heather L. Huelster, Billie Gould, et al. · European Urology · 47
Common germline-somatic variant interactions in advanced urothelial cancer
2020 · Aram Vosoughi, Tuo Zhang, et al. · Nature Communications · 42
PDF
The Paris System “atypical urothelial cells” category: can the current criteria be improved?
2020 · Aram Vosoughi, Atousa Ordobazari, et al. · Journal of the American Society of Cytopathology · 24
Enumeration and molecular characterization of circulating tumor cells as an innovative tool for companion diagnostics in breast cancer
2020 · Malini Harigopal, Diane Kowalski, et al. · Expert Review of Molecular Diagnostics · 17
Protein Kinase Cβ Is Required for Lupus Development in Sle Mice
2012 · David Oleksyn, Mary Pulvino, et al. · Arthritis & Rheumatism · 17
From Detection to Cure – Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer
2024 · Joshua A. Linscott, Hiroko Miyagi, et al. · Current Oncology Reports · 16
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis
2024 · Kentaro Ohara, André Figueiredo Rendeiro, et al. · Nature Communications · 14
PDF
Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma
2022 · Yumeng Zhang, Premsai Kumar, et al. · Cells · 13
PDF
Frozen section evaluation via dynamic real-time nonrobotic telepathology system in a university cancer center by resident/faculty cooperation team
2018 · Aram Vosoughi, Paul Taylor Smith, et al. · Human Pathology · 10
Transverse myelitis presenting in a patient with Hughes-Stovin syndrome
2015 · Jason Margolesky, Leticia Tornes, et al. · Multiple Sclerosis and Related Disorders · 9
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023 · Lucie Van Emmenis, Sheng-Yu Ku, et al. · Cancer Research Communications · 7
PDF
PKK deficiency in B cells prevents lupus development in Sle lupus mice
2017 · D. Oleksyn, J. Zhao, et al. · Immunology Letters · 5
ROICellTrack: a deep learning framework for integrating cellular imaging modalities in subcellular spatial transcriptomic profiling of tumor tissues
2025 · Xiaofei Song, Xiaoqing Yu, et al. · Bioinformatics · 4
PDF
Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease
2023 · Kyle M. Rose, Heather L. Huelster, et al. · Nature Reviews Urology · 4
PDF
A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the Bladder
2024 · Casey Liveringhouse, Austin J. Sim, et al. · Clinical Genitourinary Cancer · 3
720TiP Phase I/II study of ipilimumab plus nivolumab (IPI-NIVO) combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma
2021 · R.K. Jain, J. Chahoud, et al. · Annals of Oncology · 3
Gene-Based Vaccination and Screening Methods to Develop Monoclonal Antibodies
2014 · M. Pirouz Daftarian, Aram Vosoughi, et al. · Methods in molecular biology · 3
Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancer
2023 · Roger Li, Shreyas Naidu, et al. · Urologic Oncology Seminars and Original Investigations · 2
Works count: 109
Citation count: 1,319
H-index: 14
I10-index: 16
Year
Topic
Type